Loading...
XSHE000503
Market cap1.37bUSD
Jan 15, Last price  
10.29CNY
1D
-1.91%
1Q
-13.75%
Jan 2017
-75.53%
Name

China Reform Health Management and Services Group Co Ltd

Chart & Performance

D1W1MN
XSHE:000503 chart
P/E
—
P/S
30.45
EPS
—
Div Yield, %
0.05%
Shrs. gr., 5y
0.27%
Rev. gr., 5y
28.16%
Revenues
330m
+6.12%
374,991,519256,372,948201,724,369208,301,909286,651,351272,498,437197,766,773162,850,417192,936,834205,906,598195,071,369193,827,322216,833,347183,993,71495,480,022129,912,815207,372,157252,515,004311,079,455330,126,718
Net income
-80m
358,074,43042,295,87427,186,5753,643,7175,415,8767,916,98012,164,23518,000,70624,094,56712,978,22924,977,28923,063,38828,021,18516,674,851017,427,722000-79,791,984
CFO
0k
53,396,229000041,558,260072,376,78665,869,118159,587,254013,410,82522,942,5300066,044,1060000
Dividend
May 31, 20040.1 CNY/sh

Profile

China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. It is involved in business that covers 177 medical insurance in 25 provinces. It is also involved in the pharmaceutical and medical business. The company was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group Co., Ltd. in May 2018. China Reform Health Management and Services Group Co., Ltd. was founded in 1986 and is based in Haikou, China.
URL
https://www.crhms.cn/
IPO date
Nov 30, 1992
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
330,127
6.12%
311,079
23.19%
Cost of revenue
307,727
309,430
Unusual Expense (Income)
NOPBT
22,400
1,649
NOPBT Margin
6.79%
0.53%
Operating Taxes
1,909
1,278
Tax Rate
8.52%
77.46%
NOPAT
20,491
372
Net income
(79,792)
 
Dividends
(4,598)
(1,351)
Dividend yield
0.04%
0.01%
Proceeds from repurchase of equity
(26,821)
BB yield
0.22%
Debt
Debt current
190,207
51,638
Long-term debt
1,348
6,975
Deferred revenue
Other long-term liabilities
(1,681)
Net debt
(906,182)
(530,797)
Cash flow
Cash from operating activities
CAPEX
(52,068)
Cash from investing activities
(51,948)
Cash from financing activities
907,977
FCF
25,868
4,220
Balance
Cash
1,379,156
589,410
Long term investments
(281,419)
Excess cash
1,081,230
573,856
Stockholders' equity
721,252
908,034
Invested Capital
890,973
178,281
ROIC
3.83%
0.29%
ROCE
1.39%
0.22%
EV
Common stock shares outstanding
910,867
898,822
Price
13.18
29.72%
10.16
-39.88%
Market cap
12,005,232
31.46%
9,132,034
-39.88%
EV
11,100,143
8,745,252
EBITDA
56,173
41,249
EV/EBITDA
197.61
212.01
Interest
5,298
1,985
Interest/NOPBT
23.65%
120.35%